The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C

Journal Title: One Health & Risk Management - Year 2020, Vol 1, Issue 1

Abstract

Introduction. Viral hepatitis C (HCV) is a significant global health problem. The risk of developing chronic HCV is up to 80% of patients, of whom 10-20% can develop liver cirrhosis or hepatocellular carcinoma which can lead to death. Treatment with direct-acting antiviral agents (DAAs) contributes to a sustained virological response (SVR) in 97-99% of cases. Material and methods. The study was conducted on 206 patients with chronic HCV who underwent two generic antiviral agent therapies: group I (103) – Sofosbuvir 400 mg + Ledipasvir 80 mg, whereas group II (103) – Sofosbuvir 400 mg + Daclatasvir 60 mg orally, once a day, for 12 weeks. The assessment of hepatitis C virus RNA and genotype, as well as the degree of hepatic fibrosis by Fibroscan, biochemical and complete blood count (CBC) indices were carried out. Results. The study results showed high efficacy of the generic DAAs treatment in patients with chronic HCV over 12 weeks. The SVR rate made up 90.3% in Sofosbuvir + Ledipasvir therapy and 86.4% – in Sofosbuvir + Daclatasvir. Similar treatment response was recorded in naive patients and those who previously underwent unsuccessful treatment with Pegylated Interferon and Ribavirin. The DAAs treatment showed the following minor adverse reactions: asthenia, headache, sleep dCiosncoclnutsiniounatsi.on. disorder, and nausea, which did not require treatment The 12-week course of DAAs therapy exhibited high SVR rate in both chronic HCV naive patients and those previously treated with Pegylated Interferon and Ribavirin.

Authors and Affiliations

Irina RUSU*, Liliana HODOROGEA, Tiberiu HOLBAN

Keywords

Related Articles

Cardiovascular damage in seronegative spondylarthriti

Introduction. Cardiovascular mortality in patients diagnosed with seronegative spondyloarthritis (SSN) is on the rise. Impairment of the cardiovascular system in ankylosing spondylitis (SpA) is 20-40%, in psoriatic arthr...

Mammal fauna of Chisinau airport, Republic of Moldova

Introduction. Airport territories are large, containing a high variety of biotopes, mostly open type, and are relatively protected against intense human activity, thus creating favorable conditions for many mammal specie...

Syntropia – acid-dependent diseases and hypertension

Introduction. With syntropy of CVD and AH, the pathology of the digestive system can exacerbate the course of AH and develop special conditions for increasing the risk of cardiovascular complications. Pharmacotherapy of...

Evaluarea riscului pentru starea de sănătate a populației în funcție de com-poziția apei potabile

Introduction. Drinking water includes a multitude of natural elements, with a strong connection between them, which through the dynamics of their modification in many cases influence the health of the population. Mate...

Epidemiology of the initial period of novel coronavirus (COVID-19) pandemic in the Republic of Moldova

Introduction. In the Republic of Moldova, the first case of COVID-19 was confirmed on March 7, followed by a significantly increasing incidence across the country. It is important to describe the clinical and epidemiolog...

Download PDF file
  • EP ID EP683644
  • DOI 10.5281/zenodo.3700945
  • Views 272
  • Downloads 0

How To Cite

Irina RUSU*, Liliana HODOROGEA, Tiberiu HOLBAN (2020). The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C. One Health & Risk Management, 1(1), -. https://europub.co.uk/articles/-A-683644